Drug Utilization Review (DUR) promotes appropriate use of pharmaceuticals in the outpatient Medicaid program through education of practitioners.

Drug Utilization Board

The Texas DUR Board is composed of physicians and pharmacists that meet quarterly to determine criteria for implementing retrospective DUR. The DUR Board meeting schedule for 2008 is:

• February 28, 2008 (Moreton Building)
  • Agenda
  • Meeting Materials
    
• April 24, 2008 (Winters Building)
  • Agenda
  • Meeting Material
• August 21, 2008 (Brown-Heatly Building)
  • Agenda
  • Meeting Materials
• November 6, 2008 (Winters Building)
  • Agenda
  • Meeting Materials

Resources:

• OBRA '90 Overview relating to Medicaid Drug Use Review
• Texas State Board of Pharmacy Prospective DUR/Patient Counseling Rules
• Drug Criteria for Out-Patient Use
• Drug Use Compendia

Other information:

• Texas Pharmaceutical and Therapeutics Committee
  

Prior Approval request forms
All completed forms should be faxed to Vendor Drug DUR at 512-491-1962.

• Growth Hormone Approval (CSHCN program)
• Human Growth Hormone Injections for Children
• Human Growth Hormone Treatment (Serostim®)
• Nutropin in Chronic Renal Insufficiency
• Orlistat (Xenical®)
• Pulmozyme and Tobi (CSHCN program)
• Sermorelin (Geref ®)
• Synagis® (CSHCN program)